TrialRheumatology (Oxford, England)2020

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).

Vinod Chandran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.